Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001193125-25-319291

Options or other derivatives

  • Director bought 2,285,714 shares at $17.49 ($39,977,138)

From the SEC's structured data for this filing

Trades in this filing

BAKER BROS. ADVISORS LP · Director

Table II: Derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-11 Purchase : show line 1 in the form $0.01 Prefunded Warrants +190,523 $17.49 $3,332,247 2,335,469 I
2025-12-11 Purchase : show line 2 in the form $0.01 Prefunded Warrants +2,095,191 $17.49 $36,644,891 25,996,310 I
Loading xslF345X05/ownership.xml…